G76763LN
| Organisms | Evidence |
|---|---|
| Homo sapiens (human) |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
|---|---|---|---|---|---|---|
| FUT2 | GDP-Fuc |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
| B(ABO) | UDP-Gal |
|
O-glycan Synthesis |
|
O-glycan Synthesis | |
| A(ABO) | UDP-GalNAc |
|
O-glycan Synthesis |
|
O-glycan Synthesis |
| Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Reference |
|---|---|---|---|---|
| ST6GALNAC1 | CMP-Neu5Ac |
|
O-glycan Synthesis |
RES 1b:a-dgal-HEX-1:5 2s:n-acetyl 3b:b-dglc-HEX-1:5 4s:n-acetyl 5b:b-dgal-HEX-1:5 6b:a-lgal-HEX-1:5|6:d LIN 1:1d(2+1)2n 2:1o(3+1)3d 3:3d(2+1)4n 4:3o(4+1)5d 5:5o(2+1)6d
| PubMed ID | Title | First Author | Publication Date | Source |
|---|---|---|---|---|
| 3345750 | Primary structure of neutral oligosaccharides derived from respiratory-mucus glycoproteins of a patient suffering from bronchiectasis, determined by combination of 500-MHz 1H-NMR spectroscopy and quantitative sugar analysis. 2. Structure of 19 oligosaccharides having the GlcNAc beta(1----3)GalNAc-ol core (type 3) or the GlcNAc beta(1----3)[GlcNAc beta(1----6)]GalNAc-ol core (type 4) | Breg J | 1988 Feb 1 |
|
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025